5Willams CD, Stengel J, Asike MI, et al. Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy:a prospective study[J ]. Gastroenterology, 2011,140( 1 ):124-131.
6Kotronen A, Pehonen M, Hakkarainen A, et al. Prediction of non- alcoholic fatty liver disease and liver fat using metabolic and geneticfactors[J]. Gastroenterology, 2009,137(3 ): 865-872.
7Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/ visceral fat and hepatic insulin resistance in non-diabeticand type 2 diabetic subjects[J]. Gastroenterology, 2007,133(2): 496-506.
8Katsiki N, Athyros VG, Karagiannis A, et al. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk ? [ J ]. Curr Vasc Phannacol, 2011,9 ( 6): 698-705.
9Hankey GJ,Eikeiboom JW,Ho WK,et al. Clinical usefulness of plasma homocysteine in vascular disease [ J 1. Med J Aust, 2004, 181 (6):314-318.
10Khajuria A,Houston DS. Induction of monoeyte tissue factor expression by homocysteinc:a possible mechanism for thrombosis [ J ].B 1 ood, 2000,96(3 ): 966-972.
